A. Visualization of wild type, pat1Δ, edc3Δ, pat1Δ or edc3Δ, lsm4Δc cells expressing the PB marker Dcp2mCherry and the SG marker Pab1GFP untreated or exposed for 30 minutes to 1 mM arsenate or 8.8 mM H2O2, irradiated with 40 mJ/cm2 UV, or incubated in SC medium without glucose for 30 minutes. B. Viability of wild type, pat1Δ; edc3Δ, pat1Δ or edc3Δ, lsm4Δc cells untreated (Unt) or treated with 1 mM arsenate, 8.8 mM H2O2 or irradiated with 40 mJ/cm2 UV analyzed by the spot test viability assay. C. Wild type, pat1Δ; edc3Δ, pat1Δ or edc3Δ, lsm4Δc cells expressing empty pGAL-vector (YCp), pGAL-GFP-UFO1, pGAL-HSP12 or MFA2-U1A (pRP1193) were grown in SC medium with 2% glucose or induced in 2% galactose medium overnight, diluted and regrown in the same media to A 600 = 0.5 for spot test analysis on SC plates with 2% glucose or 2% galactose, respectively. D. WB analysis of w.t or edc3Δ, pat1Δ cells expressing UFO1, HSP12 or MFA2 from the GAL promoter. Glu (noninducing conditions) and Gal (inducing). The intensities of each protein band were normalized to the α-tubulin loading control using ImageJ . E. Comparison of UFO1 and HSP12 mRNA decay. pGAL-GFP-UFO1 or pGAL-HSP12 was expressed in w.t or edc3Δ, pat1Δ cells by overnight induction with 2% galactose. Next morning cells at A 600 = 0.5 were washed and transferred to SC medium with 4% glucose. Samples were collected immediately after addition of glucose and at the times indicated and analyzed by qRT-PCR. mRNA levels were normalized to ACT1 and to time 0 (untreated log cells).